What Are the Symptoms of Internal Bleeding From Blood Thinners?

Internal bleeding caused by blood thinners can announce itself through obvious signs like vomiting blood or passing dark, tarry stools, but it can also creep in with symptoms that look like something else entirely: unexplained fatigue, a new headache that won’t quit, or sudden pain in the abdomen or groin with no clear cause. The danger is that anticoagulants, by design, impair the body’s ability to form clots, so a bleed that would normally seal itself off can keep expanding for hours. Recognizing the full range of symptoms, from the dramatic to the deceptively mild, is the difference between catching a bleed early and ending up in a crisis.

Gastrointestinal Bleeding Is the Most Common Type

The gut is where blood thinners cause trouble most often. This is partly because the digestive tract is a long stretch of tissue with a rich blood supply, and partly because some anticoagulants aren’t fully absorbed during digestion. The unabsorbed drug can act directly on the lining of the stomach and intestines, which may damage the protective barrier or interfere with healing of small erosions that would normally go unnoticed.¹ That local effect, combined with the systemic thinning of the blood, makes the GI tract especially vulnerable.

The symptoms depend on where in the tract the bleeding originates. Upper GI bleeds, from the esophagus, stomach, or upper small intestine, tend to produce:

Hematemesis: Vomiting blood, which may look bright red or resemble dark coffee grounds if the blood has been partially digested.
Melena: Black, tarry, foul-smelling stools caused by blood that has traveled through the intestines and been broken down along the way.

Lower GI bleeds, originating in the colon or rectum, more often produce hematochezia, which is bright red or maroon blood in the stool. However, a brisk upper GI bleed can also produce bright red rectal bleeding if the volume is large enough that blood moves through the gut quickly. Either way, dark stools or visible blood in the toilet should be treated as urgent in anyone on an anticoagulant. Doctors typically recommend an upper endoscopy when a patient on blood thinners presents with melena, hematemesis, hematochezia, or signs of blood loss like a drop in blood pressure upon standing.²

Subtler GI bleeding is easy to miss. A slow, steady ooze from the stomach lining might not produce visible blood in the stool at all. Instead, you might notice increasing fatigue, lightheadedness, pale skin, or shortness of breath on exertion, all of which point to anemia from gradual blood loss. A sudden drop in energy or exercise tolerance that you can’t explain by anything else warrants a blood count check, especially if you’ve been on an anticoagulant for months.

Bleeding Inside the Skull

Intracranial hemorrhage is the most feared complication of blood thinners because of how little room the brain has to accommodate swelling. About seven in ten anticoagulant-related intracranial bleeds are intracerebral hematomas, meaning blood collects within the brain tissue itself, and roughly six in ten of those are fatal. Most of the remaining cases are subdural hematomas, where blood pools between the brain and its outer covering.³ What makes these bleeds particularly treacherous is their pace: in about half of anticoagulated patients with an intracerebral hematoma, the bleeding expands slowly over 12 to 24 hours, so early symptoms can seem minor before rapidly worsening.

The warning signs to watch for include:

Sudden severe headache: Often described as the worst headache of your life, different from a typical tension headache or migraine.
Confusion or difficulty speaking: Slurred speech, trouble finding words, or seeming “out of it” for no obvious reason.
One-sided weakness or numbness: Facial drooping, arm weakness, or leg heaviness on one side, mimicking stroke symptoms.
Vision changes: Blurred or double vision, or loss of vision in one eye.
Nausea and vomiting: Particularly when paired with a headache or altered consciousness.
Drowsiness progressing to unresponsiveness: A person who becomes increasingly hard to rouse needs immediate evaluation.

One important detail: people on anticoagulants are more likely to develop subdural hematomas from trivially low-energy injuries, like a simple fall from standing height.⁴ A bump on the head that would mean nothing to someone not on blood thinners can set off a bleed that doesn’t become symptomatic for days or even weeks. If you’re on an anticoagulant and hit your head, even gently, err on the side of getting checked out, especially if headaches, confusion, or personality changes develop afterward.

Retroperitoneal and Abdominal Bleeding

The retroperitoneal space, the area behind the abdominal cavity that houses the kidneys, major blood vessels, and parts of the pancreas and colon, is a site where bleeding can go unnoticed for a surprisingly long time. There’s room for a large volume of blood to accumulate before it compresses anything enough to cause obvious symptoms. In a small case series of patients on warfarin, retroperitoneal hemorrhage presented with abdominal pain, blood in the urine, or both.⁵

When a retroperitoneal hematoma grows large enough, it can press on nearby nerves, particularly the femoral nerve that runs through the hip and into the thigh. This produces a distinctive pattern: sudden severe groin pain, weakness in the quadriceps muscle making it difficult to straighten the knee or walk, abdominal distension, and signs of hemodynamic instability like a racing heart and falling blood pressure.⁶ The leg weakness in particular can be misread as a back problem or a neurological issue unrelated to bleeding, which delays the correct diagnosis.

Abdominal bleeding doesn’t always come from the retroperitoneal space. Blood can collect around the spleen, within the liver, or in the peritoneal cavity itself. Symptoms in these cases include diffuse abdominal tenderness, a rigid or distended belly, pain that worsens over hours, and signs of shock (cold clammy skin, rapid pulse, low blood pressure). If you’re on a blood thinner and develop unexplained abdominal pain that doesn’t resolve, especially if it’s accompanied by lightheadedness, that’s a reason to get to an emergency department rather than wait for a morning appointment.

Muscle and Soft Tissue Bleeds

Bleeding into muscles or the soft tissues around joints is an underappreciated risk of anticoagulant therapy. Most people think of bleeding as something that shows up externally or in the stool, but blood can pool deep inside a muscle compartment, sometimes triggered by minimal activity. In one reported case, a man on apixaban developed a large hematoma in his anterior thigh compartment after riding a roller coaster, an activity that wouldn’t cause a muscle bleed in someone with normal clotting. The pressure from the trapped blood was severe enough to require emergency surgery. Eight months later, the same patient experienced a recurrence in the same thigh while simply lying in bed.⁷

The symptoms of a muscle compartment bleed include intense, deep pain in the affected limb that seems out of proportion to any activity or injury, swelling that feels tight and firm rather than soft, decreased ability to move the limb, and numbness or tingling downstream from the bleeding site. In the thighs and calves, this can mimic a deep vein thrombosis, which adds a cruel irony: the medication taken to prevent clots can produce symptoms that look exactly like a clot. If you’re on an anticoagulant and develop sudden, severe limb pain with swelling, don’t assume it’s a pulled muscle and wait it out. Compartment syndrome can permanently damage nerves and muscle tissue if the pressure isn’t relieved quickly.

More superficial bleeding shows up as large, spontaneous bruises that you don’t remember causing, or bruises that are much larger or more painful than you’d expect from a minor bump. While a few extra bruises on your shins are generally harmless, widespread bruising, purplish patches on the trunk, or bruises that keep expanding over days should prompt a conversation with your prescribing doctor.

Less Common but Serious Bleeding Sites

Blood in the urine, called hematuria, is another symptom to be alert to. It may look pink, red, or cola-colored, or it may only be detected by a dipstick test at a routine visit. On a blood thinner, even a small source of bleeding in the kidneys or bladder, something that would normally seal off on its own, can persist and worsen. Hematuria always deserves investigation in someone on anticoagulant therapy, both because it may signal an underlying issue like a kidney stone or bladder lesion and because the anticoagulant can turn a minor bleed into a significant one.

Bleeding into the lungs, known as diffuse alveolar hemorrhage, is rare but serious. Symptoms include coughing up blood or blood-tinged sputum, progressive shortness of breath, and sometimes chest tightness. This complication has been documented as a rare event in patients on anticoagulant therapy, and it tends to look similar to a pneumonia or a worsening of underlying lung disease, which can delay recognition.

Bleeding into the pericardium, the sac around the heart, is another uncommon but life-threatening possibility. Signs include chest pain that changes with position (often worse when lying flat, better when sitting forward), shortness of breath, and in severe cases a dangerously low blood pressure from the heart being compressed by accumulated blood. Joint bleeds, eye hemorrhages, and prolonged bleeding from gums or nosebleeds are also seen in anticoagulated patients, though these are usually less dangerous and more quickly noticed.

Why Some People Bleed and Others Don’t

Not everyone on a blood thinner faces the same risk. Several factors tilt the odds. Age is a big one: older adults have more fragile blood vessels, are more prone to falls, and often have reduced kidney and liver function that changes how quickly they clear the drug from their system. Kidney disease in particular amplifies the risk. A large community study found that people with moderately reduced kidney function had about 50% higher odds of GI bleeding compared to those with normal kidneys, and those with severely reduced kidney function faced a sevenfold increase in risk.⁸ Even mild levels of protein leakage in the urine, a marker of early kidney damage, were associated with a meaningfully higher bleeding risk.

Drug interactions add another layer. Combining an anticoagulant with aspirin, an anti-inflammatory drug like ibuprofen, or certain antidepressants (SSRIs) increases the bleeding hazard. One less obvious interaction involves telmisartan, a common blood pressure medication: it interferes with the body’s ability to clear some direct oral anticoagulants, which causes drug levels to climb and roughly quintupled the odds of bleeding in one study.⁹ If you’re on a blood thinner and your doctor adds or changes another medication, it’s worth asking specifically about bleeding interactions.

Genetics also play a role that is only now being mapped. Researchers have identified specific gene variants that influence how patients on rivaroxaban metabolize the drug and how likely they are to bleed over the following year.¹⁰ Similarly, variations in genes involved in blood vessel growth and repair have been linked to warfarin-associated bleeding in at least one population study.¹¹ Genetic testing for bleeding risk is not yet part of standard clinical practice for most anticoagulants, but the research suggests that some people are genuinely more susceptible to bleeding than others through no fault of their own medication adherence.

How Different Blood Thinners Compare

The type of anticoagulant you take affects where and how you’re likely to bleed. Warfarin, the older standard, works systemically by suppressing clotting factors throughout the body. It has a well-known bleeding profile but requires regular blood monitoring, and its effect is heavily influenced by diet, other medications, and genetics. The newer direct oral anticoagulants (DOACs), including dabigatran, rivaroxaban, apixaban, and edoxaban, target a single step in the clotting process and are generally more predictable.

A meta-analysis comparing DOACs to warfarin in patients with atrial fibrillation found that DOACs were associated with about a 20% lower risk of major bleeding overall and a roughly 40% lower risk of intracranial hemorrhage. However, the risk of GI bleeding was not statistically different between the two categories.¹² So if your main concern is a brain bleed, the newer drugs have a meaningful safety advantage. If your concern is GI bleeding, the advantage is less clear.

Among the DOACs themselves, there are differences in how much unabsorbed drug passes through the gut. Dabigatran has very low oral absorption, with the vast majority of each dose passing through the intestines in a form that can become locally active, which may contribute to its higher reported rates of GI side effects like dyspepsia and bleeding compared to some of the factor Xa inhibitors. Rivaroxaban and apixaban are absorbed more efficiently but still leave a fraction of drug in contact with the gut lining.¹³

When to Treat It as an Emergency

Any suspected internal bleeding on a blood thinner should be taken seriously, but certain presentations call for calling 911 rather than driving yourself to an urgent care clinic. The high-urgency signs include:

Vomiting blood or passing large amounts of blood rectally
Sudden severe headache with confusion or weakness
Fainting or near-fainting, especially with a rapid heartbeat
Severe abdominal or groin pain with a rigid belly or swelling
Sudden limb pain with tightness, swelling, and inability to move the limb
Coughing up blood

In the emergency department, the immediate priority is to reverse or reduce the anticoagulant effect. For warfarin, this typically involves vitamin K and sometimes fresh frozen plasma or prothrombin complex concentrates. For the newer DOACs, specific reversal agents now exist: idarucizumab for dabigatran, and andexanet alfa for rivaroxaban and apixaban. When specific reversal agents aren’t available or the situation is critical, activated prothrombin complex concentrates have been used to help control life-threatening DOAC-associated bleeding.¹⁴ The window for effective intervention is often narrow, particularly for brain bleeds, which is why speed matters so much.

One common question is whether to stop taking the blood thinner at the first sign of a problem. The answer is nuanced and depends on why you’re taking it. A person on an anticoagulant because they have an artificial heart valve or a recent pulmonary embolism faces real risks from stopping the drug, too. This is a decision to make with a doctor, ideally in real time rather than by skipping doses on your own. If you can’t reach your doctor and you’re actively bleeding, going to an emergency department is the right call, as they can weigh the risks both ways.

Subtle Signs That Accumulate Over Time

Not all anticoagulant-related bleeding is dramatic. Chronic low-grade bleeding is probably more common than acute hemorrhagic events, but it rarely makes the headlines. The classic scenario is someone who has been on a blood thinner for months and gradually becomes more tired, more short of breath climbing stairs, paler than usual, and maybe a little dizzy when standing up quickly. A blood test reveals iron-deficiency anemia, and the culprit turns out to be slow, invisible bleeding from the GI tract.

Iron-deficiency anemia that develops during anticoagulant therapy should be investigated rather than simply treated with iron supplements. Endoscopy often reveals a source, whether it’s a stomach ulcer, a vascular malformation in the colon, or something else that the anticoagulant is preventing from healing. Treating only the anemia without looking for the source means the bleeding continues and the anemia comes back.

Other gradual signs that can point to chronic occult bleeding include unusually heavy or prolonged menstrual periods in premenopausal women, blood detected on routine urinalysis without visible color change, and recurrent nosebleeds that are harder to stop than they used to be. None of these on their own is necessarily alarming, but a pattern of several at once, or any one that’s clearly getting worse over time, deserves attention. Keeping a simple log of unusual bruises, nosebleeds, or changes in stool color can help you and your doctor spot trends that would otherwise be easy to dismiss individually.

Practical Steps for People on Anticoagulants

Living on a blood thinner doesn’t mean living in fear of bleeding, but it does mean staying alert. A few practical habits lower the risk and improve early detection. Staying consistent with follow-up appointments allows your doctor to check hemoglobin levels periodically, catching slow bleeds before they become symptomatic. If you’re on warfarin, keeping your INR in the target range through consistent diet and medication timing reduces your risk substantially. If you’re on a DOAC, be aware that kidney function changes over time and affects drug clearance, so periodic kidney tests matter.

Avoiding unnecessary concurrent use of NSAIDs like ibuprofen or naproxen is one of the simplest risk-reduction steps available, since these drugs damage the stomach lining and impair platelet function at the same time. Acetaminophen is generally a safer choice for pain relief, though high doses carry liver risks of their own. Alcohol in excess also increases bleeding risk, both by affecting liver function and by directly irritating the stomach lining. Moderate, consistent use is generally considered acceptable, but binge drinking while anticoagulated is a genuinely dangerous combination.

Fall prevention deserves more attention than it usually gets, especially for older adults. Given that anticoagulated patients can develop serious brain bleeds from a seemingly trivial fall, practical measures like removing loose rugs, installing grab bars in bathrooms, wearing well-fitting shoes, and managing medications that cause dizziness are not fussy precautions. They’re legitimate strategies to avoid the single most dangerous bleeding complication of anticoagulant therapy.